Login / Signup

High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli.

Pinyo RattanaumpawanIrving NachamkinWarren B BilkerJason A RoyJoshua P MetlayTheoklis E ZaoutisEbbing Lautenbachnull null
Published in: Annals of clinical microbiology and antimicrobials (2017)
Our study demonstrated the negative impact of reduced FQ susceptibility on the treatment response to FQ therapy in FQSEC UTIs. This negative impact may be more intensified in other serious infections. Future studies in other clinical situations should be conducted to fill the gap of knowledge.
Keyphrases
  • escherichia coli
  • urinary tract infection
  • healthcare
  • stem cells
  • combination therapy
  • bone marrow
  • cystic fibrosis
  • current status